The National Health Service (General Medical Services Contracts) (Prescription of Drugs Etc.) (Wales) Regulations 2004

Regulation 3

SCHEDULE 2 E+W DRUGS ON MEDICINES TO BE ORDERED ONLY IN CERTAIN CIRCUMSTANCES

Commencement Information

I1 Sch. 2 in force at 1.4.2004, see reg. 1(1)

Column 1	Column 2	Column 3
Drugs	Patient	Condition
In this Schedule— “EEA Agreement” means the Agreement on the European Economic Area signed at Oporto on 2nd May 1992(4) as adjusted by the Protocol signed at Brussels on 17th March 1993(5) and as amended so far as is relevant to these Regulations, by Decision of the EEA Joint Committee No 7/94 of 21st March 1994(6); “EEA State” means a State which is a contracting party to the EEA Agreement or Switzerland.
Clobazam	Any patient	Treatment of epilepsy
Cyanocobalamin Tablets	A patient who is a vegan or who has a proven vitamin B12 deficiency of dietary origin	Treatment or prevention of vitamin B12 deficiency
Locabiotal Aerosol	Any patient	Treatment of infections and inflammation of the oropharynx
Niferex Elixir 30ml Paediatric Dropper Bottle	Infants born prematurely	Prophylaxis and treatment of iron deficiency
Nizoral Cream	Any patient	Treatment of seborrhoeic dermatitis and pityriasis versicolor
The following drugs for the treatment of erectile dysfunction— Alprostadil (Caverject), (MUSE), (Viridal) Apomorphine Hydrochloride (Uprima) Moxisylyte Hydrochloride (Erecnos) Sildenafil (Viagra) Tadalafil (Cialis) Thymoxamine Hydrochloride (Erecnos) Vardenafil (Levitra)	(a) a man with erectile dysfunction who on 14th September 1998 was receiving a course of treatment under the Act, the National Health Service (Scotland) Act 1978(1) or the Health and Personal Social Services (Northern Ireland) Order 1972(2) for this condition with any of the following drugs— Alprostadil (Caverject), (MUSE), (Viridal) Apomorphine Hydrochloride (Uprima) Moxisylyte Hydrochloride Assembly (Erecnos) Sildenafil (Viagra) Tadalafil (Cialis) Thymoxamine Hydrochloride (Erecnos); or (b) man who is a national of an EEA State who is entitled to treatment by virtue of Article 7(2) of Council Regulation 1612/68(3) as extended by the EEA Agreement or by virtue of any other enforceable Community right who has erectile dysfunction and was on 14th September 1998 receiving a course of treatment under a national health insurance system of an EEA State for this condition with any of the drugs listed in sub-paragraph (a); or (c) a man who is not a national of an EEA State but who is the member of the family of such a national who has an enforceable Community right to be treated no less favourably than the national in the provision of medical treatment and has erectile dysfunction and was being treated for that condition on 14th September 1998 with any of the drugs listed in sub-paragraph (a); or (d) a man who is suffering from any of the following— diabetes multiple sclerosis parkinson’s disease poliomyelitis prostate cancer severe pelvic injury single gene neurological disease spina bifida spinal cord injury; or (e) a man who is receiving treatment for renal failure by dialysis; or (f) a man who has had the following surgery — prostatectomy radical pelvic surgery renal failure treated by transplant	Treatment of erectile dysfunction

(1)

1978 c. 29.

(2)

S.I. 1972/1265 (NI 14).

(3)

O.J. No. L257, 19.10.68, p.22.

(4)

Cm. 2073 and O.J. No. L1, 3.1.1944, p.3.

(5)

Cm. 2183 and O.J.No. L1, 3.1.1994, p.572.

(6)

O.J. No. L160, 28.6. 1996, p.1.